HLHS Cause to Cure

Hypoplastic Left Heart Syndrome Program from Mayo Clinic

Share this:
February 22, 2016

Join Us on March 5 for IMPACT at Mayo Clinic

By suzannerferguson

IMPACT - MGSThis year, the Mayo Clinic Office of Applied Scholarship and Education Science has partnered with Regenerative Medicine Minnesota to sponsor the Innovative Minds Partnering to Advance Curative Therapies (IMPACT) program. IMPACT is a competitive program open to Minnesota undergraduate students that encourages them to submit hypotheses for three different challenges.

On March 5, participating teams will come to Mayo Clinic to present their ideas through both poster and oral presentations. Winning teams will then be selected for each of the IMPACT challenges. The winning team members will receive $1,000 and the opportunity to conduct their research at Mayo Clinic for the summer.

This year’s challenge questions are the following:

  1. What is the underlying cause of hypoplastic left heart syndrome (HLHS)?
  2. What is the non-genetic cause of bipolar disorder?
  3. What is the cause of sporadic fallopian tube epithelium transformation to ovarian cancer?

We hope you’ll join us on March 5 in the Landow Atrium, Gonda Building to hear undergraduate students present their hypotheses on HLHS, bipolar disorder and ovarian cancer.

For more information on the program, visit www.mayo.edu/research/crm/impact.

The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) is a collaborative network of specialists bonded by the vision of delaying or preventing heart failure for individuals affected by congenital heart defects including HLHS. The specialized team is addressing the various aspects of these defects by using research and clinical strategies ranging from basic science, to diagnostic imaging to regenerative therapies.

Tags: CHD, Congenital Heart Disease, HLHS, Hypoplastic Left Heart Syndrome, IMPACT

Please login or register to post a reply.
Contact Us · Privacy Policy